Patents by Inventor Ask Puschl

Ask Puschl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7138407
    Abstract: The invention provides compounds represented by the general formula I wherein the substituents are defined in the application. The compounds are useful in the treatment of an affective disorder, including depression, anxiety disorders including general anxiety disorder and panic disorder and obsessive compulsive disorder.
    Type: Grant
    Filed: December 6, 2005
    Date of Patent: November 21, 2006
    Assignee: H. Lundbeck A/S
    Inventors: Thomas Ruhland, Garrick Paul Smith, Benny Bang-Andersen, Ask Puschl, Ejner Knud Moltzen, Kim Andersen
  • Publication number: 20060100242
    Abstract: The invention provides compounds represented by the general formula (I) wherein the substituents are defined in the application. The compounds are useful in the treatment of an affective disorder, including depression, anxiety disorders including general anxiety disorder and panic disorder and obsessive compulsive disorder.
    Type: Application
    Filed: April 2, 2004
    Publication date: May 11, 2006
    Applicant: H.Lundbeck A/S
    Inventors: Ask Puschl, Benny Bang-Andersen, Morten Jorgensen, Thomas Ruhland, Tine Stensbol
  • Publication number: 20060089368
    Abstract: The invention provides compounds represented by the general formula I wherein the substituents are defined in the application. The compounds are useful in the treatment of an affective disorder, including depression, anxiety disorders including general anxiety disorder and panic disorder and obsessive compulsive disorder.
    Type: Application
    Filed: December 6, 2005
    Publication date: April 27, 2006
    Applicant: H. Lundbeck A/S
    Inventors: Thomas Ruhland, Garrick Smith, Benny Bang-Andersen, Ask Puschl, Ejner Moltzen, Kim Andersen
  • Publication number: 20060084662
    Abstract: The invention provides compounds represented by the general formula I wherein the substituents are defined in the application. The compounds are useful in the treatment of an affective disorder, including depression, anxiety disorders including general anxiety disorder and panic disorder and obsessive compulsive disorder.
    Type: Application
    Filed: December 6, 2005
    Publication date: April 20, 2006
    Applicant: H. Lundbeck A/S
    Inventors: Thomas Ruhland, Garrick Smith, Benny Bang-Andersen, Ask Puschl, Ejner Moltzen, Kim Andersen
  • Publication number: 20050085530
    Abstract: The present invention relates to aminoindane derivatives having the formula I wherein X, Y, U, R1-2, R13-16 and R are as defined in the claims, or an acid addition salt thereof. The compounds of the invention posses the combined effect of serotonin reuptake inhibition and norepinephrine uptake inhibition.
    Type: Application
    Filed: December 18, 2002
    Publication date: April 21, 2005
    Inventors: Klaus Bogeso, Ask Puschl, Jan Kehler, Peter Bregnedal
  • Publication number: 20050014740
    Abstract: The invention provides compounds represented by the general formula I wherein the substituents are defined in the application. The compounds are useful in the treatment of an affective disorder, including depression, anxiety disorders including general anxiety disorder and panic disorder and obsessive compulsive disorder.
    Type: Application
    Filed: October 2, 2002
    Publication date: January 20, 2005
    Inventors: Thomas Ruhland, Garrick Smith, Benny Bang-Andersen, Ask Puschl, Ejner Moltzen, Kim Andersen
  • Publication number: 20040063906
    Abstract: The present invention concerns peptide nucleic acid (PNA) sequences, which are modified in order to obtain novel PNA molecules with enhanced properties.
    Type: Application
    Filed: November 10, 2003
    Publication date: April 1, 2004
    Inventors: Peter E. Nielsen, Ask Puschl